4.7 (671) · $ 18.99 · In stock
Cancers, Free Full-Text
Frontiers Patients' knowledge about their involvement in
Inclusion & Diversity in Clinical Trials - EUPATI Toolbox
Overcoming Barriers to Referral for Chimeric Antigen Receptor T
Systematic review - Wikipedia
Frontiers Application of Real-World Data to External Control
Advance care planning in the community in the context of COVID-19
Chapter 24: Including non-randomized studies on intervention
Overcoming Barriers to Referral for Chimeric Antigen Receptor T
Participation of rural patients in clinical trials at a multisite
Diagnostic randomized controlled trials: the final frontier